C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
10/2011
10/27/2011	US20110263565 Compounds
10/27/2011	US20110263561 Novel pyrrolidone derivatives for use as MetAP-2 inhibitors
10/27/2011	US20110263559 Indazole compounds useful as ketohexokinase inhibitors
10/27/2011	US20110263558 Azetidines as MEK Inhibitors for the Treatment of Proliferative Diseases
10/27/2011	US20110263543 Anti inflammatory compounds
10/27/2011	US20110263541 Kinase inhibitors and their use as pharmaceutical agents
10/27/2011	US20110263431 Pyrrole derivatives for use as plant growth regulators
10/27/2011	US20110262425 Therapeutic agent for mll leukemia and moz leukemia of which molecular target is m-csf receptor, and use thereof
10/27/2011	US20110262354 Cyanine-containing compounds for cancer imaging and treatment
10/26/2011	EP2380888A1 Compound having triazole ring structure with pyridyl group attached thereto, and organic electroluminescent element
10/26/2011	EP2380881A1 Novel bicyclic heterocyclic compound
10/26/2011	EP2380631A1 Heteroaryl derivatives as DGAT1 inhibitors
10/26/2011	EP2379533A1 N-substituted saturated heterocyclic sulfone compounds with cb2 receptor agonistic activity
10/26/2011	EP2379532A1 Compounds useful for inhibiting chk1
10/26/2011	EP2379530A1 Pyrimidine indole derivatives for treating cancer
10/26/2011	EP2379527A1 Pyrimidin- 2 -ylamino derivatives and their use to treat inflammation
10/26/2011	EP2379525A1 Cyclic pyrimidin-4-carboxamides as ccr2 receptor antagonists for treatment of inflammation, asthma and copd
10/26/2011	EP2379524A1 Serotonin 5-ht2b receptor inhibitors
10/26/2011	EP2379075A1 Triazole derivatives for treatment of alzheimer's disease
10/26/2011	EP2185546B1 Co-crystals and pharmaceutical compositions comprising the same
10/26/2011	EP2181985B1 Antiviral Agent
10/26/2011	EP2057141B1 Pyrimidone compounds as gsk-3 inhibitors
10/26/2011	EP1943219B1 5-lipoxygenase-activating protein (flap) inhibitors
10/26/2011	EP1916245B1 Indole derivative having pgd2 receptor antagonist activity
10/26/2011	EP1518855B1 Diaminopyrimidinecarboxa mide derivative
10/26/2011	EP1425010B1 Substituted indoles and their use as integrin antagonists
10/26/2011	CN102227422A Heterocyclic jak kinase inhibitors
10/26/2011	CN102227420A Quinazolinone, quinolone and related analogs as sirtuin modulators
10/26/2011	CN102227412A Fungicide hydroximoyl-heterocycles derivatives
10/26/2011	CN102227407A Hepatitis c virus inhibitors
10/26/2011	CN102225934A Preparation method of 4,5-di(1H-tetrazole-5-yl)-1H-imidazole
10/26/2011	CN102225930A Method of treatment of age-related macular degeneration(AMD)
10/26/2011	CN101195614B Production of balofloxacin and purification process thereof
10/25/2011	US8044203 Chiral indole intermediates and their fluorescent cyanine dyes containing functional groups
10/25/2011	US8044199 N-formyl hydroxylamines compounds
10/25/2011	US8044103 Cyclic dipeptides and azetidinone compounds and their use in treating CNS injury and neurodegenerative disorders
10/25/2011	US8044090 N-(2-arylethyl)benzylamines as antagonists of the 5-HT6 receptor
10/25/2011	US8044089 3-3-di-substituted-oxindoles as inhibitors of translation initiation
10/25/2011	US8044088 1-acetic acid-indole derivatives with PGD2 antagonist activity
10/25/2011	US8044054 Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses
10/25/2011	US8044040 e.g. 3-{3-Cyano-6-[(2,2-dimethyl-propyl)-methyl-amino]-5-fluoro-pyridin-2-ylamino}-N-methoxy-4-methyl-benzamide; via p38 kinase inhibition; (anilino)(halo)pyrimidine or (anilino)(amino)pyrimidine derivatives; rheumatoid arthritis, psoriasis, Crohn's Disease, osteoarthritis or osteoporosis
10/25/2011	US8043607 UV-absorbers for ophthalmic lens materials
10/25/2011	CA2657355C Tetrahydro isoquinoline derivatives, preparation methods and medicinal uses thereof
10/20/2011	WO2011130500A1 Formulations of a pyridazine bipyrazinyl
10/20/2011	WO2011130459A1 Novel glucokinase activators and methods of using same
10/20/2011	WO2011128699A2 Novel process
10/20/2011	WO2011128381A1 Triazole compounds as ksp inhibitors
10/20/2011	WO2011128329A1 Triazole-substituted anthranilic acid amides as pesticides
10/20/2011	WO2011128279A1 Arylethynyl derivatives
10/20/2011	WO2011082268A3 Substituted naphthalenyl-pyrimidine compounds
10/20/2011	WO2011080684A9 Process for the preparation of candesartan cilexetil
10/20/2011	WO2011052923A3 Novel 1,6-disubstituted indole compounds as protein kinase inhibitors
10/20/2011	US20110257398 Compositions and Methods Including Cell Death Inducers and Procaspase Activation
10/20/2011	US20110257395 Chemical Process
10/20/2011	US20110257391 Process for production of quinazoline derivative
10/20/2011	US20110257389 Cross-linked cyclic amine compounds and agents for pest control
10/20/2011	US20110257379 Lead compound of anti-hypertensive drug and method for screening the same
10/20/2011	US20110257237 Process for the preparation of crystalline forms of sunitinib malate
10/20/2011	US20110257235 Triazolium and imidazolium salts and uses thereof
10/20/2011	US20110257211 Small-Molecule Choline Kinase Inhibitors as Anti-Cancer Therapeutics
10/20/2011	US20110257210 Benzimidazole derivatives and their use for modulating the gabaa receptor complex
10/20/2011	US20110257193 Fused imidazole derivatives as trpv3 antagonist
10/20/2011	US20110257191 Hydrazine-Substituted Anthranilic Acid Derivatives
10/20/2011	US20110257181 Pyridazinone derivatives
10/20/2011	US20110257178 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
10/20/2011	US20110257177 Benzylthiotetrazole inhibitors of store operated calcium release
10/20/2011	US20110257169 Novel hydroxy-6-heteroarylphenanthridines and their use as pde4 inhibitors
10/20/2011	US20110257164 Dipeptidyl peptidase iv inhibitors
10/20/2011	US20110257154 Compounds and compositions as protein kinase inhibitors
10/20/2011	US20110257014 1-(Heteroaryl)pyrazol-4-ylacetic acids, processes for their preparation and their use as herbicides and plant growth regulators
10/20/2011	US20110256550 Novel reagents for directed biomarker signal amplification
10/20/2011	US20110256549 Novel reagents for directed biomarker signal amplification
10/20/2011	US20110256457 Nonaqueous secondary battery and flame retardant for the same
10/20/2011	US20110253218 Dye for photoelectric conversion device and photoelectric conversion device
10/20/2011	DE102010014933A1 Materialien für elektronische Vorrichtungen Materials for electronic devices
10/20/2011	CA2794406A1 Triazole compounds as ksp inhibitors
10/20/2011	CA2786216A1 Arylethynyl derivatives
10/19/2011	EP2378586A1 Organic electronic devices using phthalimide compounds
10/19/2011	EP2377854A1 N-phenyl-dioxo-hydropyrimidines useful as hepatitis C virus (HCV) inhibitors
10/19/2011	EP2377850A1 TRPV1 vanilloid receptor antagonists with a bicyclic portion
10/19/2011	EP2377539A1 Quinazoline analogs as receptor tyrosine kinase inhibitors
10/19/2011	EP2376594A1 Novel compound for organic photoelectric device and organic photoelectric device including the same
10/19/2011	EP2376495A2 Compositions of protein receptor tyrosine kinase inhibitors
10/19/2011	EP2376485A1 Pyrazine derivatives useful as inhibitors of atr kinase
10/19/2011	EP2376478A2 Pyridyloxyindoles inhibitors of vegf-r2 and use thereof for treatment of disease
10/19/2011	EP2376475A1 4-azetidinyl-1-heteroaryl-cyclohexanol antagonists of ccr2
10/19/2011	EP2376464A1 Fungicide hydroximoyl-heterocycles derivatives
10/19/2011	EP2376454A2 Inhibitors of diacylglycerol acyltransferase
10/19/2011	EP2376447A2 Dipeptidyl peptidase iv inhibitors
10/19/2011	EP2376197A2 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
10/19/2011	EP2376083A1 Quinazoline inhibitors of bace 1 and methods of using
10/19/2011	EP2375904A1 Biaryl carboxamides
10/19/2011	EP1923387B1 Acylguanidine derivative or salt thereof
10/19/2011	EP1482931B1 Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
10/19/2011	CN1906161B N-sulfonyldicarboximide containing tethering compounds
10/19/2011	CN1251097B Phthalazines with angiogenesis inhibiting activity
10/19/2011	CN102224149A Pyrazole compounds for controlling invertebrate pests
10/19/2011	CN102224143A 1h-benz imidazole-5-carboxamides as anti-inflammatory agents
10/19/2011	CN102224142A Novel pyrazole-3-carboxamide derivative having 5-ht2b receptor antagonist activity
10/19/2011	CN102219779A Method for synthetizing irbesartan

1 ... 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 ... 626